QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01065493
Recruitment Status : Unknown
Verified November 2014 by Silverchair Science & Communications, LLC.
Recruitment status was:  Active, not recruiting
First Posted : February 9, 2010
Last Update Posted : November 19, 2014
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Silverchair Science & Communications, LLC

Brief Summary:
QuitAdvisorMD: A point-of-care tool for brief smoking cessation interventions Under a Phase II SBIR grant supported by NIH/NIDA, we are developing QUITAdvisorMD: a point-of-care, patient-centered resource for counseling patients who smoke or use tobacco products. It is based on the principles of Motivational Interviewing, a non-confrontational and very effective method for intervening and treating these patients; the 5 A's of behavioral interventions; and the Transtheoretical Model of Change. Through a point and click interface, the tool uses a series of interview questions designed to motivate patients to stop smoking by first assessing their stage of change and then offering effective stage-based interventions and interview techniques. The tool also offers stage-tailored patient information, a clinician educational reference, and the ability to communicate support information patients via email and/or text message.

Condition or disease Intervention/treatment Phase
Smoking Tobacco Use Disorder Other: QuitAdvisorMD Software Algorithm Behavioral: Standard Smoking Cessation Counseling Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions
Study Start Date : January 2011
Estimated Primary Completion Date : April 2015
Estimated Study Completion Date : April 2015

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Software Assisted Lifestyle Counseling Other: QuitAdvisorMD Software Algorithm
QuitAdvisorMD, a set of brief clinical assessments, counseling scripts and intervention instruments for smoking cessation in primary care settings

Active Comparator: Lifestyle Counseling
Status quo smoking cessation counseling.
Behavioral: Standard Smoking Cessation Counseling
Standard Smoking Cessation Counseling

Primary Outcome Measures :
  1. The goal of the evaluation is to assess the ability of QuitAdvisorMD to influence smoking cessation as measured by the primary outcome of the increase in physician initiated smoking cessation counseling. [ Time Frame: 12 Months ]

Secondary Outcome Measures :
  1. Secondary outcomes will include, 1) the increase in ability of clinicians to provide appropriate stage-based smoking cessation assistance, and 2) the increase in patient quit attempts. [ Time Frame: 12 Months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • any physician providing care for members of Southern Health through primary care and have access to a point-of-care computing device (Smartphone, desktop PC, etc) during patient visits.

Exclusion Criteria:

  • Lack of appropriate computing device

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01065493

United States, Virginia
University of Virginia Health System
Charlottesville, Virginia, United States, 22908
Sponsors and Collaborators
Silverchair Science & Communications, LLC
National Institute on Drug Abuse (NIDA)
Principal Investigator: George Reynolds, BA Silverchair, Inc
Principal Investigator: Scott Strayer, MD University of Virginia Health System

Responsible Party: Silverchair Science & Communications, LLC Identifier: NCT01065493     History of Changes
Other Study ID Numbers: R44DA026682 ( U.S. NIH Grant/Contract )
R44DA026682 ( U.S. NIH Grant/Contract )
First Posted: February 9, 2010    Key Record Dates
Last Update Posted: November 19, 2014
Last Verified: November 2014

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders